<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Chao Ren | Qizhao Research Group</title>
    <link>https://likelet.github.io/author/chao-ren/</link>
      <atom:link href="https://likelet.github.io/author/chao-ren/index.xml" rel="self" type="application/rss+xml" />
    <description>Chao Ren</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 01 Sep 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_512x512_fill_lanczos_center_3.png</url>
      <title>Chao Ren</title>
      <link>https://likelet.github.io/author/chao-ren/</link>
    </image>
    
    <item>
      <title>p.P476S mutation of RBPJL inhibits the efficacy of anti-PD-1 therapy in oesophageal squamous cell carcinoma by blunting T-cell responses</title>
      <link>https://likelet.github.io/publication/journal-article-p476s/</link>
      <pubDate>Tue, 01 Sep 2020 00:00:00 +0000</pubDate>
      <guid>https://likelet.github.io/publication/journal-article-p476s/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers</title>
      <link>https://likelet.github.io/publication/journal-article-tumor/</link>
      <pubDate>Fri, 01 Nov 2019 00:00:00 +0000</pubDate>
      <guid>https://likelet.github.io/publication/journal-article-tumor/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Association of frequent amplification of chromosome 11q13 in esophageal squamous cell cancer with clinical benefit to immune check point blockade</title>
      <link>https://likelet.github.io/publication/conference-paper-association/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>https://likelet.github.io/publication/conference-paper-association/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer</title>
      <link>https://likelet.github.io/publication/journal-article-chemotherapy/</link>
      <pubDate>Thu, 01 Dec 2016 00:00:00 +0000</pubDate>
      <guid>https://likelet.github.io/publication/journal-article-chemotherapy/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
